mRNA COVID vaccine and myocarditis in adolescents

Hong Kong Med J. 2021 Oct;27(5):326-327. doi: 10.12809/hkmj215120. Epub 2021 Aug 16.

Authors

M Y W Kwan¹, G T Chua², C B Chow^{1

2}, S S L Tsao², K K W To³, K Y Yuen³, Y L Lau², P Ip²

Affiliations

¹ Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong.
² Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.
³ Department of Microbiology, Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

PMID: 34393110
DOI: 10.12809/hkmj215120

No abstract available

Publication types

Editorial

MeSH terms

Adolescent
COVID-19 Vaccines
COVID-19*
Humans
Myocarditis*
RNA, Messenger
SARS-CoV-2

Substances

COVID-19 Vaccines
RNA, Messenger